Pharma giant Merck expects Trump’s tariffs to cost the company $200 million

Merck is following Johnson & Johnson’s lead and reporting an expected financial hit from tariffs imposed by the Trump administration.

In an April 24 earnings call, executives said they expect $200 million in tariff-related costs in 2025. Merck lowered its full-year profit expectations from $8.88–$9.03 per share to $8.82–$8.97 per share.

The news comes a week after J&J executives said they expect $400 million in tariff-induced expenses in 2025.

Robert Davis...